Electrospray Ionization Mass Spectrometry Analysis of Lysophospholipids in Human Ascitic Fluids: Comparison of the Lysophospholipid Contents in Malignant vs Nonmalignant Ascitic Fluids
- 1 March 2001
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 290 (2) , 302-313
- https://doi.org/10.1006/abio.2001.5000
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Development of Our Current Understanding of Bioactive LysophospholipidsAnnals of the New York Academy of Sciences, 2000
- Sphingosine‐1‐phosphate modulates growth and adhesion of ovarian cancer cellsFEBS Letters, 1999
- Sphingosine 1-phosphate: a prototype of a new class of second messengersJournal of Leukocyte Biology, 1999
- Human ovarian cancer of the surface epitheliumBiochemical Pharmacology, 1997
- Molecular diversity of sphingolipid signallingFEBS Letters, 1997
- Lysophosphatidic acid: G-protein signalling and cellular responsesCurrent Opinion in Cell Biology, 1997
- Growth factors in human ovarian cancerCancer Treatment Reviews, 1997
- Lysophospholipids activate ovarian and breast cancer cellsBiochemical Journal, 1995
- Lipid second messengersCell, 1994
- Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.Journal of Clinical Investigation, 1990